ESMO-Magnitude of Clinical Benefit Scale
The ESMO-MCBS is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The leading professional organisation for medical oncology
Access the latest resources available on the portal
Help us transform state-of-the-art oncology evidence and research into recommendations for daily clinical practice.
Join the webinar and submit your question to the leading experts in the field
Reserved to ESMO members
Webcast and presentation slides are available to the entire Oncology community. Log in to your ESMO account and access now
Application deadline: 19 April 2021: do not miss the opportunity to join the course.
Read the full interview with ESMO President Solange Peters on the pivotal role medical oncologists should have in cancer prevention.
The ESMO-MCBS is a validated and reproducible tool to assess the magnitude of clinical benefit for cancer medicines.
Do not miss the opportunity! Submit your application by 11 May 2021
Evidence for efficacy is based on the results from the CHECKMATE-649 study
It includes age and lung metastases as additional adverse prognostic factors and uses a single cut-off of LDH at 2.5× ULN
A new analysis from US show that response to genome-targeted therapy increased from 2.73% in 2006 to 7.04% in 2020
Evidence for efficacy and safety is based on the results from the TROPHY study
Approval is based on population pharmacokinetic modelling analyses
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.